Dikkat Eksikliği Hiperaktivite Bozukluğu ve Madde Kullanım Bozukluğu

Adisetiyo, V., & Gray, K. M. (2017). Neuroimaging the neural correlates of increased risk for substance use disorders in attention‐deficit/hyperactivity disorder—a systematic review. The American journal on addictions, 26(2), 99-111.

Alvarenga, P. G., Mastrorosa, R. S., Rosário, M. C., & Rey, J. M. (2012). IACAPAP e-Textbook of Child and Adolescent Mental Health.

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

Callovini, T., Janiri, D., Segatori, D., Mastroeni, G., Kotzalidis, G. D., Di Nicola, M., & Sani, G. (2024). Examining the Myth of Prescribed Stimulant Misuse among Individuals with Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Pharmaceuticals, 17(8), 1076. https://doi.org/10.3390/ph17081076

Capusan, A. J., Bendtsen, P., Marteinsdottir, I., & Larsson, H. (2019). Comorbidity of adult ADHD and its subtypes with substance use disorder in a large population-based epidemiological study. Journal of attention disorders, 23(12), 1416-1426.

Chiappini, S., Gramuglia, P. D., Mosca, A., Cavallotto, C., Miuli, A., Corkery, J. M., ... & Martinotti, G. (2024). Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. Frontiers in Psychiatry, 15, 1508732.

Choi, W. S., Woo, Y. S., Wang, S. M., Lim, H. K., & Bahk, W. M. (2022). The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One, 17(11), e0277175.

Coetzee, C., Schellekens, A. F., Truter, I., & Meyer, A. (2023). Effect of past pharmacotherapy for attention-deficit/hyperactivity disorder on substance use disorder. European Addiction Research, 29(1), 9-18.

Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of addiction medicine, 5(1), 1-8.

Evren, C., Dalbudak, E., Evren, B., Can, Y., & Umut, G. (2014). The severity of attention deficit hyperactivity symptoms and its relationship with lifetime substance use and psychological variables among 10th grade students in Istanbul. Comprehensive psychiatry, 55(7), 1665-1670.

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., ... & Wang, Y. (2021). The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience & biobehavioral reviews, 128, 789-818.

Goriounova, N. A., & Mansvelder, H. D. (2012). Short-and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harbor perspectives in medicine, 2(12), a012120.

Groenman, A. P., Janssen, T. W., & Oosterlaan, J. (2017). Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 56(7), 556-569.

Hernandez, M., Dambreville, N., & Levin, F. R. (2022). ADHD and Co-Occurring Substance Use Disorders. In E. Akerele (Ed.), Substance and Non-Substance Related Addictions: A Global Approach (pp. 19-37). Springer International Publishing.

Ivanov, I., Bjork, J. M., Blair, J., & Newcorn, J. H. (2022). Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence. Neuroscience & Biobehavioral Reviews, 135, 104575.

Karaçetin G., Tekden M., Ocakoğlu B. Alkol-madde kullanım bozuklukları. (2024) Ercan E. S., Perçinel Yazıcı İ., Bilaç Ö., Yazıcı K.U., Kılıçoğlu A.G. Çocuk ve ergenlerde psikopatoloji. (pp. 706-707). Nobel Tıp Kitabevi.

Koller, D., Mitjans, M., Kouakou, M., Friligkou, E., Cabrera-Mendoza, B., Deak, J. D., Llonga, N., Pathak, G. A., Stiltner, B., Løkhammer, S., Levey, D. F., Zhou, H., Hatoum, A. S., Kember, R. L., Kranzler, H. R., Stein, M. B., Corominas, R., Demontis, D., Artigas, M. S., . . . Polimanti, R. (2024). Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders. Psychiatry Research, 333, 115758. https://doi.org/https://doi.org/10.1016/j.psychres.2024.115758

Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014). Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24‐week randomized placebo‐controlled trial. Addiction, 109(3), 440-449.

Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., ... & Grabowski, J. (2015). Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA psychiatry, 72(6), 593-602.

Long, Y., Pan, N., Ji, S., Qin, K., Chen, Y., Zhang, X., ... & Gong, Q. (2022). Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis. Translational Psychiatry, 12(1), 368

López-Ojeda, W., & Hurley, R. A. (2024). Vaping and the brain: Effects of electronic cigarettes and e-liquid substances. The Journal of Neuropsychiatry and Clinical Neurosciences, 36(1), A5-5.

Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co‐occurring ADHD and substance use disorders. The American Journal on Addictions, 16, 45-56.

Middeldorp, C. M., Hammerschlag, A. R., Ouwens, K. G., Groen-Blokhuis, M. M., St. Pourcain, B., Greven, C. U., Pappa, I., Tiesler, C. M. T., Ang, W., Nolte, I. M., Vilor-Tejedor, N., Bacelis, J., Ebejer, J. L., Zhao, H., Davies, G. E., Ehli, E. A., Evans, D. M., Fedko, I. O., Guxens, M., . . . Boomsma, D. I. (2016). A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 896-905.e896. https://doi.org/https://doi.org/10.1016/j.jaac.2016.05.025

Oscar-Berman, M., & Marinković, K. (2007). Alcohol: effects on neurobehavioral functions and the brain. Neuropsychology review, 17, 239-257.

Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A. S., Van De Glind, G., ... & Hendriks, V. (2020). International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. European addiction research, 26(4-5), 223-232.

Oomen, P. P., Van Hell, H. H., & Bossong, M. G. (2018). The acute effects of cannabis on human executive function. Behavioural pharmacology, 29(7), 605-616.

Rohner, H., Gaspar, N., Philipsen, A., & Schulze, M. (2023). Prevalence of attention deficit hyperactivity disorder (ADHD) among substance use disorder (SUD) populations: Meta-analysis. International journal of environmental research and public health, 20(2), 1275.

Serra-Pinheiro, M. A., Coutinho, E. S., Souza, I. S., Pinna, C., Fortes, D., Araújo, C., ... & Mattos, P. (2013). Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. Journal of attention disorders, 17(6), 459-469.

Taubin, D., Wilson, J. C., & Wilens, T. E. (2022). ADHD and substance use disorders in young people: considerations for evaluation, diagnosis, and pharmacotherapy. Child and Adolescent Psychiatric Clinics of North America, 31(3), 515-530.

Textbook of addiction treatment : international perspectives. (2021). In N. el-Guebaly, G. Carrà, M. Galanter, & A. M. Baldacchino (Eds.), Springer Nature eBook (Second edition). Springer. https://doi.org/10.1007/978-3-030-36391-8

Van de Glind, G., Brynte, C., Skutle, A., Kaye, S., Konstenius, M., Levin, F., ... & Franck, J. (2020). The international collaboration on ADHD and substance abuse (ICASA): mission, results, and future activities. European addiction research, 26(4-5), 173-178.

Vilar‐Ribó, L., Sánchez‐Mora, C., Rovira, P., Richarte, V., Corrales, M., Fadeuilhe, C., ... & Soler Artigas, M. (2021). Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 186(3), 140-150.

Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179-185.

Wilens, T. E., Martelon, M., Joshi, G., Bateman, C., Fried, R., Petty, C., & Biederman, J. (2011). Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 50(6), 543-553.

Wimberley, T., Agerbo, E., Horsdal, H. T., Ottosen, C., Brikell, I., Als, T. D., Demontis, D., Børglum, A. D., Nordentoft, M., Mors, O., Werge, T., Hougaard, D., Bybjerg-Grauholm, J., Hansen, M. B., Mortensen, P. B., Thapar, A., Riglin, L., Langley, K., & Dalsgaard, S. (2020). Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction, 115(7), 1368-1377. https://doi.org/https://doi.org/10.1111/add.14910

World Health Organization. (1994). Lexicon of alcohol and drug terms. World Health Organization.

Yule, A. M., Martelon, M., Faraone, S. V., Carrellas, N., Wilens, T. E., & Biederman, J. (2017). Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis. Journal of psychiatric research, 85, 49-55.

Zaso, M. J., Park, A., & Antshel, K. M. (2020). Treatments for adolescents with comorbid ADHD and substance use disorder: A systematic review. Journal of Attention Disorders, 24(9), 1215-1226.

Adisetiyo, V., & Gray, K. M. (2017). Neuroimaging the neural correlates of increased risk for substance use disorders in attention‐deficit/hyperactivity disorder—a systematic review. The American journal on addictions, 26(2), 99-111.

Alvarenga, P. G., Mastrorosa, R. S., Rosário, M. C., & Rey, J. M. (2012). IACAPAP e-Textbook of Child and Adolescent Mental Health.

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

Callovini, T., Janiri, D., Segatori, D., Mastroeni, G., Kotzalidis, G. D., Di Nicola, M., & Sani, G. (2024). Examining the Myth of Prescribed Stimulant Misuse among Individuals with Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Pharmaceuticals, 17(8), 1076. https://doi.org/10.3390/ph17081076

Capusan, A. J., Bendtsen, P., Marteinsdottir, I., & Larsson, H. (2019). Comorbidity of adult ADHD and its subtypes with substance use disorder in a large population-based epidemiological study. Journal of attention disorders, 23(12), 1416-1426.

Chiappini, S., Gramuglia, P. D., Mosca, A., Cavallotto, C., Miuli, A., Corkery, J. M., ... & Martinotti, G. (2024). Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. Frontiers in Psychiatry, 15, 1508732.

Choi, W. S., Woo, Y. S., Wang, S. M., Lim, H. K., & Bahk, W. M. (2022). The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One, 17(11), e0277175.

Coetzee, C., Schellekens, A. F., Truter, I., & Meyer, A. (2023). Effect of past pharmacotherapy for attention-deficit/hyperactivity disorder on substance use disorder. European Addiction Research, 29(1), 9-18.

Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of addiction medicine, 5(1), 1-8.

Evren, C., Dalbudak, E., Evren, B., Can, Y., & Umut, G. (2014). The severity of attention deficit hyperactivity symptoms and its relationship with lifetime substance use and psychological variables among 10th grade students in Istanbul. Comprehensive psychiatry, 55(7), 1665-1670.

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., ... & Wang, Y. (2021). The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience & biobehavioral reviews, 128, 789-818.

Goriounova, N. A., & Mansvelder, H. D. (2012). Short-and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harbor perspectives in medicine, 2(12), a012120.

Groenman, A. P., Janssen, T. W., & Oosterlaan, J. (2017). Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 56(7), 556-569.

Hernandez, M., Dambreville, N., & Levin, F. R. (2022). ADHD and Co-Occurring Substance Use Disorders. In E. Akerele (Ed.), Substance and Non-Substance Related Addictions: A Global Approach (pp. 19-37). Springer International Publishing.

Ivanov, I., Bjork, J. M., Blair, J., & Newcorn, J. H. (2022). Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence. Neuroscience & Biobehavioral Reviews, 135, 104575.

Karaçetin G., Tekden M., Ocakoğlu B. Alkol-madde kullanım bozuklukları. (2024) Ercan E. S., Perçinel Yazıcı İ., Bilaç Ö., Yazıcı K.U., Kılıçoğlu A.G. Çocuk ve ergenlerde psikopatoloji. (pp. 706-707). Nobel Tıp Kitabevi.

Koller, D., Mitjans, M., Kouakou, M., Friligkou, E., Cabrera-Mendoza, B., Deak, J. D., Llonga, N., Pathak, G. A., Stiltner, B., Løkhammer, S., Levey, D. F., Zhou, H., Hatoum, A. S., Kember, R. L., Kranzler, H. R., Stein, M. B., Corominas, R., Demontis, D., Artigas, M. S., . . . Polimanti, R. (2024). Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders. Psychiatry Research, 333, 115758. https://doi.org/https://doi.org/10.1016/j.psychres.2024.115758

Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014). Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24‐week randomized placebo‐controlled trial. Addiction, 109(3), 440-449.

Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., ... & Grabowski, J. (2015). Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA psychiatry, 72(6), 593-602.

Long, Y., Pan, N., Ji, S., Qin, K., Chen, Y., Zhang, X., ... & Gong, Q. (2022). Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis. Translational Psychiatry, 12(1), 368

López-Ojeda, W., & Hurley, R. A. (2024). Vaping and the brain: Effects of electronic cigarettes and e-liquid substances. The Journal of Neuropsychiatry and Clinical Neurosciences, 36(1), A5-5.

Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co‐occurring ADHD and substance use disorders. The American Journal on Addictions, 16, 45-56.

Middeldorp, C. M., Hammerschlag, A. R., Ouwens, K. G., Groen-Blokhuis, M. M., St. Pourcain, B., Greven, C. U., Pappa, I., Tiesler, C. M. T., Ang, W., Nolte, I. M., Vilor-Tejedor, N., Bacelis, J., Ebejer, J. L., Zhao, H., Davies, G. E., Ehli, E. A., Evans, D. M., Fedko, I. O., Guxens, M., . . . Boomsma, D. I. (2016). A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 896-905.e896. https://doi.org/https://doi.org/10.1016/j.jaac.2016.05.025

Oscar-Berman, M., & Marinković, K. (2007). Alcohol: effects on neurobehavioral functions and the brain. Neuropsychology review, 17, 239-257.

Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A. S., Van De Glind, G., ... & Hendriks, V. (2020). International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. European addiction research, 26(4-5), 223-232.

Oomen, P. P., Van Hell, H. H., & Bossong, M. G. (2018). The acute effects of cannabis on human executive function. Behavioural pharmacology, 29(7), 605-616.

Rohner, H., Gaspar, N., Philipsen, A., & Schulze, M. (2023). Prevalence of attention deficit hyperactivity disorder (ADHD) among substance use disorder (SUD) populations: Meta-analysis. International journal of environmental research and public health, 20(2), 1275.

Serra-Pinheiro, M. A., Coutinho, E. S., Souza, I. S., Pinna, C., Fortes, D., Araújo, C., ... & Mattos, P. (2013). Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. Journal of attention disorders, 17(6), 459-469.

Taubin, D., Wilson, J. C., & Wilens, T. E. (2022). ADHD and substance use disorders in young people: considerations for evaluation, diagnosis, and pharmacotherapy. Child and Adolescent Psychiatric Clinics of North America, 31(3), 515-530.

Textbook of addiction treatment : international perspectives. (2021). In N. el-Guebaly, G. Carrà, M. Galanter, & A. M. Baldacchino (Eds.), Springer Nature eBook (Second edition). Springer. https://doi.org/10.1007/978-3-030-36391-8

Van de Glind, G., Brynte, C., Skutle, A., Kaye, S., Konstenius, M., Levin, F., ... & Franck, J. (2020). The international collaboration on ADHD and substance abuse (ICASA): mission, results, and future activities. European addiction research, 26(4-5), 173-178.

Vilar‐Ribó, L., Sánchez‐Mora, C., Rovira, P., Richarte, V., Corrales, M., Fadeuilhe, C., ... & Soler Artigas, M. (2021). Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 186(3), 140-150.

Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179-185.

Wilens, T. E., Martelon, M., Joshi, G., Bateman, C., Fried, R., Petty, C., & Biederman, J. (2011). Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 50(6), 543-553.

Wimberley, T., Agerbo, E., Horsdal, H. T., Ottosen, C., Brikell, I., Als, T. D., Demontis, D., Børglum, A. D., Nordentoft, M., Mors, O., Werge, T., Hougaard, D., Bybjerg-Grauholm, J., Hansen, M. B., Mortensen, P. B., Thapar, A., Riglin, L., Langley, K., & Dalsgaard, S. (2020). Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction, 115(7), 1368-1377. https://doi.org/https://doi.org/10.1111/add.14910

World Health Organization. (1994). Lexicon of alcohol and drug terms. World Health Organization.

Yule, A. M., Martelon, M., Faraone, S. V., Carrellas, N., Wilens, T. E., & Biederman, J. (2017). Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis. Journal of psychiatric research, 85, 49-55.

Zaso, M. J., Park, A., & Antshel, K. M. (2020). Treatments for adolescents with comorbid ADHD and substance use disorder: A systematic review. Journal of Attention Disorders, 24(9), 1215-1226.